Patent details

Basic Information

Publication number:

EP1503788

PCT Application Number:

PCT/US/2003/013063

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP037264892

PCT Publication Number:

WO/2003/090695

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF ALPHA-GALACTOSIDASE A DEFICIENCY

French Title of Invention:

TRAITEMENT D'UN DEFICIT EN ALPHA-GALACTOSIDASE A

German Title of Invention:

BEHANDLUNG DES ALPHA-GALACTOSIDASE A MANGELS

SPC Number:

Dates

Filing date:

25/04/2003

Grant date:

29/06/2011

EP Publication Date:

29/06/2011

PCT Publication Date:

06/11/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/02/2005

EP B1 Publication Date:

29/06/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

25/04/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/04/2021

 

 

Name:

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Address:

1-1, Doshomachi 4-chome, Chuo-ku, 541-0045, Osaka-Shi, Osaka, Japan (JP)

History of Owners

From:

25/04/2003

To:

28/04/2021

Name:

Shire Human Genetic Therapies Inc.

Address:

195 Albany Street, Cambridge MA 02139, United States (US)

Agent

Name:

MARKS & CLERK LLP

From:

03/08/2011

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

BOROWSKI Marianne

Address:

United States (US)

2

Name:

LOVEDAY Kenneth

Address:

United States (US)

3

Name:

TRECO Douglas, A.

Address:

United States (US)

Priority

Priority Number:

375584 P

Priority Date:

25/04/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/43;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2021/06

Publication date:

04/05/2021

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20210000177A

Date Registered:

28/04/2021

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

Baker & McKenzie

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Address:

1-1, Doshomachi 4-chome, Chuo-ku, 541-0045, Osaka-Shi, Osaka, Japan (JP)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

22/03/2022

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56
28/04/2021	Request For Change	33
28/04/2021	Outgoing Correspondence	1